Department of Community Health, Universiti Kebangsaan Malaysia, Kuala Lumpur, MY.
Department of Medical Education, Universiti Kebangsaan Malaysia, Kuala Lumpur, MY.
Glob Heart. 2023 Mar 16;18(1):12. doi: 10.5334/gh.1173. eCollection 2023.
Electronic Health (eHealth) interventions as a secondary prevention tool to empower patients' health in decision-making and behaviour.
With the growing body of evidence supporting the use of eHealth interventions, the intention is to conduct a meta-analysis on various health outcomes of eHealth interventions among ischaemic heart disease (IHD) patients.
Based on PRISMA guidelines, eligible studies were searched through databases of Web of Science, Scopus, PubMed, EBSCOHost, and SAGE (PROSPERO registration CRD42021290091). Inclusion criteria were English language and randomised controlled trials published between 2011 to 2021 exploring health outcomes that empower IHD patients with eHealth interventions. RevMan 5.4 was utilised for meta-analysis, sensitivity analysis, and risk of bias (RoB) assessment while GRADE software for generating findings of physical health outcomes. Non-physical health outcomes were analysed using SWiM (synthesis without meta-analysis) method.
This review included 10 studies, whereby, six studies with 895 participants' data were pooled for physical health outcomes. Overall, the RoB varied significantly across domains, with the majority was low risks, a substantial proportion of high risks and a sizeable proportion of unclear. With GRADE evidence of moderate to high quality, eHealth interventions improved low density lipoprotien (LDL) levels in IHD patients when compared to usual care after 12 months of interventions (SMD -0.26, 95% CI [-0.45, -0.06], I = 0%, p = 0.01). Significance appraisal in each domain of the non-physical health outcomes found significant findings for medication adherence, physical activity and dietary behaviour, while half of the non-significant findings were found for other behavioural outcomes, psychological and quality of life.
Electronic Health interventions are found effective at lowering LDL cholesterol in long-term but benefits remain inconclusive for other physical and non-physical health outcomes for IHD patients. Integrating sustainable patient empowerment strategies with the advancement of eHealth interventions by utilising appropriate frameworks is recommended for future research.
电子健康(eHealth)干预措施作为一种二级预防工具,可以增强患者在决策和行为方面的健康能力。
随着越来越多的证据支持使用电子健康干预措施,本研究旨在对缺血性心脏病(IHD)患者的各种电子健康干预措施的健康结果进行荟萃分析。
根据 PRISMA 指南,通过 Web of Science、Scopus、PubMed、EBSCOHost 和 SAGE(PROSPERO 注册 CRD42021290091)数据库搜索符合条件的研究。纳入标准为 2011 年至 2021 年间发表的、使用电子健康干预措施增强 IHD 患者能力的健康结果的英语语言和随机对照试验。使用 RevMan 5.4 进行荟萃分析、敏感性分析和偏倚风险(RoB)评估,同时使用 GRADE 软件生成身体健康结果的发现。非身体健康结果使用 SWiM(无荟萃分析的综合)方法进行分析。
本综述纳入了 10 项研究,其中有 6 项研究的 895 名参与者的数据被合并用于身体健康结果。总体而言,各领域的 RoB 差异显著,大多数为低风险,相当一部分为高风险,还有相当一部分为不确定风险。使用 GRADE 证据质量为中高度,与常规护理相比,电子健康干预措施在 12 个月的干预后可降低 IHD 患者的低密度脂蛋白(LDL)水平(SMD-0.26,95%CI[-0.45,-0.06],I=0%,p=0.01)。对非身体健康结果的每个领域进行显著性评估发现,药物依从性、身体活动和饮食行为有显著发现,而其他行为结果、心理和生活质量有一半是非显著发现。
电子健康干预措施在长期内降低 LDL 胆固醇方面是有效的,但对 IHD 患者的其他身体健康和非身体健康结果的益处仍不确定。建议在未来的研究中,整合可持续的患者赋权策略和电子健康干预措施的进步,利用适当的框架。